TABLE 1.
Fungus | Associated cancer | Main hypothetical molecular mechanisms | References |
C. albicans | Oral cancers | Form biofilm, produce hydrolase, and metabolize alcohol into carcinogenic acetaldehyde. | Marttila et al., 2013; Alnuaimi et al., 2015, 2016 |
Increases p63 and vimentin expression and decreases E-cadherin expression. | Lo Muzio et al., 2007; Kushwaha et al., 2019; Vadovics et al., 2022 | ||
Zymosan from the fungal cell wall promotes the proliferation of oral squamous cell carcinoma (OSCC) cells through the TLR2/MyD88/NF-κB signaling pathway. Moreover, zymosan can promote the expression of E-cadherin, enhance the adhesion of C. albicans to OSCC cells, and further increase IL-1β production in OSCC cells, and promote cancerous inflammation. | Chen et al., 2020 | ||
Produce endogenous nitrosamines. | Krogh, 1990 | ||
CaADH1 gene is involved in OSCC either with or without metastasis. | Hafed et al., 2019 | ||
Gastric cancer (GC) | Reduction in the diversity and richness of fungi in the stomach contributes to the pathogenesis of GC. | Zhong et al., 2021 | |
Colorectal cancer (CRC) | Enteric fungal microbiota dysbiosis and ecological alterations. Candida albicans increases glycolysis levels in macrophages through the HIF-1 pathway, prompting IL-7 secretion and release from macrophages. The increase of IL-7 effectively promotes the expression level of Stat3 and AhR transcription factors in intestinal innate lymphocytes 3 (ILC3), which then increases the level of IL-22 secretion, thus promoting the proliferation of intestinal epithelial cells and the progression of CRC. |
Coker et al., 2019; Zhu et al., 2021 | |
Breast tumor | Induce Tregs and result in dysregulation of cytokine network and thereby facilitate tumor growth. | Ahmadi et al., 2019 | |
Liver cancer | Reprogramm tumor cell metabolism and contributes to the cancer progression dependent on NLRP6. | Liu et al., 2022 |
CaADH1, Candida albicans alcohol dehydrogenase 1; OSCC, oral squamous cell carcinoma; ILC3, intestinal innate lymphocytes 3.